Literature DB >> 15750015

Proteome analysis of maternal serum samples for trisomy 21 pregnancies using ProteinChip arrays and bioinformatics.

Anne Busch1, Susanne Michel, Constance Hoppe, Dominik Driesch, Uwe Claussen, Ferdinand von Eggeling.   

Abstract

A surface-enhanced laser desorption/ionization time of flight (SELDI-TOF)-based ProteinChip System was used as a tool for rapid discovery and identification of protein patterns in serum that discriminate between trisomy 21 and unaffected pregnancies. We analyzed 24 serum samples from women carrying a trisomy 21 pregnancy and 32 with an unaffected pregnancy, ranging from 10.0 to 14.0 weeks of gestation. The resulting protein profiles were submitted to a clustering algorithm, a rule extraction, a rating, and a rule base construction step. For the generated combined rule base, the specificity and sensitivity for the prediction of a trisomy 21 pregnancy reach 97% and 91%, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750015     DOI: 10.1369/jhc.4B6377.2005

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  9 in total

1.  Posttranslational modifications of transthyretin are serum markers in patients with mycosis fungoides.

Authors:  Niko Escher; Martin Kaatz; Christian Melle; Christina Hipler; Mirjana Ziemer; Dominik Driesch; Uwe Wollina; Ferdinand von Eggeling
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

2.  Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer.

Authors:  Astrid Enkelmann; Joana Heinzelmann; Ferdinand von Eggeling; Martina Walter; Alexander Berndt; Heiko Wunderlich; Kerstin Junker
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-04       Impact factor: 4.553

3.  Comparative proteomic analysis of normal and tumor stromal cells by tissue on chip based mass spectrometry (toc-MS).

Authors:  Niko Escher; Günther Ernst; Christian Melle; Alexander Berndt; Joachim H Clement; Kerstin Junker; Karlheinz Friedrich; Orlando Guntinas-Lichius; Ferdinand von Eggeling
Journal:  Diagn Pathol       Date:  2010-01-28       Impact factor: 2.644

Review 4.  Early pregnancy diagnosis in bovines: current status and future directions.

Authors:  Ashok K Balhara; Meenakshi Gupta; Surender Singh; Ashok K Mohanty; Inderjeet Singh
Journal:  ScientificWorldJournal       Date:  2013-12-05

Review 5.  Quantitative mass spectrometry-based techniques for clinical use: biomarker identification and quantification.

Authors:  Kathryn L Simpson; Anthony D Whetton; Caroline Dive
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-11-18       Impact factor: 3.205

6.  Bioinformatics Investigation and Contribution of Other Chromosomes Besides Chromosome 21 in the Risk of Down Syndrome Development.

Authors:  Mona Zamanian Azodi; Mostafa Rezaei Tavirani; Majid Rezaei Tavirani; Mohammad Rostami Nejad
Journal:  Basic Clin Neurosci       Date:  2021-01-01

7.  Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ).

Authors:  Varaprasad Kolla; Paul Jenö; Suzette Moes; Sevgi Tercanli; Olav Lapaire; Mahesh Choolani; Sinuhe Hahn
Journal:  J Biomed Biotechnol       Date:  2009-11-05

8.  Biomarker development for non-invasive prenatal diagnosis of fetal aneuploidies: predictive reliability and potential clinical application.

Authors:  Aggeliki Kolialexi; Athanasios K Anagnostopoulos; Georgia Tounta; Aris Antsaklis; Ariadni Mavrou; George Th Tsangaris
Journal:  EPMA J       Date:  2011-05-18       Impact factor: 6.543

9.  Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids.

Authors:  Alain Mange; Caroline Desmetz; Virginie Bellet; Nicolas Molinari; Thierry Maudelonde; Jerome Solassol
Journal:  Proteome Sci       Date:  2008-01-11       Impact factor: 2.480

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.